NCT02973347

Brief Summary

Mechanical ventilation has become one of the most important supportive treatment methods to save the life of critically ill children over time. Ventilator-associated pneumonia (VAP) is a common complication of mechanical ventilation. It is one of the leading causes of hospital-acquired infections in the Paediatric Intensive Care Unit (PICU).VAP can aggravate patients' condition and have adverse effect on mechanical ventilation. Moreover, VAP is associated with significant increased mortality. In those critical ill patients, the catabolism increased, the anabolism decreased, which can induce negative nitrogen balance. The consensus of optimal nutrition therapy in pediatric critical care in the Asia-Pacific, released in 2014, clearly recommended that early enteral nutrition support, which begin within 24-48 hours after admitting in PICU, can significantly reduce the prevalence and mortality of nosocomial infection. Intermittent enteral feeding and continual enteral feeding are the most common methods of enteral nutrition at present. There is no final conclusion about the association between enteral nutrition methods and VAP. Thus, the relationship between enteral feeding and VAP has long been a controversial issue. There is little clinical research on the correlation between enteral nutrition and VAP in children with mechanical ventilation, and mostly were observational studies which lacks strong evidence. How to choose the appropriate enteral nutrition remains an urgent need in PICU clinical work. Therefore, it is necessary for us to analyze the relationship between enteral feeding and VAP in critically ill children. This study would perform a two-year research with mechanical ventilated patients in PICU of four children hospitals in Shanghai, which aim to determine the relationship between different enteral feeding methods and VAP, to collect the baseline characteristic data of ventilated children, to analyze the risk factors for VAP in PICU patients. The results from our study would contribute to improving the standard of care for children undergoing mechanical ventilation, reducing their lung injury and improving prognosis.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
400

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2017

Typical duration for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 22, 2016

Completed
3 days until next milestone

First Posted

Study publicly available on registry

November 25, 2016

Completed
1 month until next milestone

Study Start

First participant enrolled

January 1, 2017

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2018

Completed
Last Updated

November 25, 2016

Status Verified

November 1, 2016

Enrollment Period

1.9 years

First QC Date

November 22, 2016

Last Update Submit

November 22, 2016

Conditions

Keywords

Enteral FeedingVentilator-Associated PneumoniaMechanical VentilationPediatric Intensive Care UnitCritical Illness

Outcome Measures

Primary Outcomes (1)

  • Ventilator-associated pneumonia

    The incidence of VAP in patients with intermittent enteral feeding strategy is compared with the incidence of VAP in patients with continuous enteral feeding strategy. Diagnosis of VAP as defined by national diagnostic criteria.

    at Day-28

Secondary Outcomes (4)

  • Duration of ICU stay

    at Day-28

  • Duration of hospital stay

    at Day-28

  • ICU mortality

    at Day-28

  • Hospital mortality

    at Day-28

Study Arms (2)

Intermittent enteral feeding

ACTIVE COMPARATOR

Intermittent enteral feeding via the nasogastric tube is applied less than 30 mins.

Other: Intermittent enteral feeding

Continuous enteral feeding

ACTIVE COMPARATOR

Continuous enteral feeding via the nasogastric tube using infusion pump is applied for 24 hours.

Other: Continuous enteral feeding

Interventions

The intervention is the schedule under which ventilated children are offered enteral feeding attempts: feed administered via the nasogastric tube less than 30 mins.

Intermittent enteral feeding

The intervention is the schedule under which ventilated children are offered enteral feeding attempts: feed administered via the nasogastric tube for 24 hours.

Continuous enteral feeding

Eligibility Criteria

Age29 Days - 16 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Age of 29 days to 16 years.
  • Subjects ventilated over or equal to 12 hours.
  • Endotracheal intubation.
  • Subjects without contraindication for enteral feeding.

You may not qualify if:

  • Newborn or age \> or equal to 16 years.
  • Subjects has been ventilated before this research.
  • Subjects ventilated less than 12 hours.
  • Invasive ventilation.
  • Subjects with severe congenital malformations.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Pneumonia, Ventilator-AssociatedCritical Illness

Condition Hierarchy (Ancestors)

Healthcare-Associated PneumoniaCross InfectionInfectionsPneumoniaRespiratory Tract InfectionsLung DiseasesRespiratory Tract DiseasesIatrogenic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Xiaodong Zhu, MD

    Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

    PRINCIPAL INVESTIGATOR
  • Yueniu Zhu, PhD

    Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

    STUDY DIRECTOR

Central Study Contacts

Lingxuezi Zhang, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 22, 2016

First Posted

November 25, 2016

Study Start

January 1, 2017

Primary Completion

December 1, 2018

Study Completion

December 1, 2018

Last Updated

November 25, 2016

Record last verified: 2016-11